• Mon, December 12, 2022
Jason Gerberry Downgraded (ALLO) to Sell and Held Target at $9 on, Dec 12th, 2022
Jason Gerberry of B of A Securities, Downgraded "Allogene Therapeutics, Inc." (ALLO) to Sell and Held Target at $9 on, Dec 12th, 2022.
Jason has made no other calls on ALLO in the last 4 months.
There are 2 other peers that have a rating on ALLO. Out of the 2 peers that are also analyzing ALLO, 0 agree with Jason's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Jason
- Debjit Chattopadhyay of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $29 on, Monday, November 21st, 2022
- Kalpit Patel of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $18 on, Thursday, September 22nd, 2022